Skip to main content
Clinical Trials/JPRN-UMIN000015952
JPRN-UMIN000015952
Recruiting
Phase 4

Study of the change of dietary intake and contents after taking selective SGLT2 inhibitor, Ipragliflozin - Selective SGLT2 inhibitor, Ipragliflozin and the change of a meal

A society for the study of SGLT2 in Aomori-ken0 sites200 target enrollmentDecember 15, 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Type 2 diabetes mellitus
Sponsor
A society for the study of SGLT2 in Aomori-ken
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2014
End Date
September 30, 2016
Last Updated
2 years ago
Study Type
Interventional,observational
Sex
All

Investigators

Sponsor
A society for the study of SGLT2 in Aomori-ken

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with allergy for Ipragliflozin 2\) Patients got severe ketosis, diabetic coma, and diabetic precoma during the past 6 months 3\) Patients with severe infectious disease and injury, and in perioperative 4\) Patients with renal dysfunction at a moderate level or high 5\) Patients whose doctor judges to unfit for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials